CRISPR/Cas9 technology generated an A to T change at position 770 (c.770A>T) resulting in a histidine to leucine substitution at amino acid 257 (p.H257L). This corresponds to a p.H285L mutation found in a patient with early-onset autoimmunity and chronic urticaria. (J:331430)